Determine your risk of passing on over 300 genetic diseases to your future child.
80% of children born with a genetic condition have no family history of that disease. CarrierMap is an expanded carrier screen that can help you plan for a healthy family.
CarrierMap is recommended for people who are planning a family or early in pregnancy.
Gain insight into the health of your pregnancy with one simple blood test.
Chromosome abnormalities such as Down syndrome impact over 1 in 107 pregnancies. ChromoMap is a non-invasive prenatal screen to assess risk for these conditions.
ChromoMap is available for women who are at least 10 weeks pregnant.
Contribute to a first-of-its-kind study on the links between genomics and infertility.
1 in 6 couples are impacted by infertility. Through large-scale research, FertilityMap seeks to optimize fertility treatment, helping more families achieve successful pregnancies.
Participation in FertilityMap is currently only open to patients of partner clinics.
Navigate the complicated world of genomics with help from Recombine’s expert genetic counselors.
Recombine is focused on comprehensive patient care and offers detailed genetic counseling pre- and post-test to help give the most complete picture of your family’s risk.
Recombine genetic counseling is available alongside CarrierMap and ChromoMap at no additional charge.
Phone: 855-OUR-GENES (855-687-4363)
Location: 1140 Broadway, Suite 1100, New York 10001
Infertility is an incredibly complex disease, and treatment, though constantly improving, often requires some level of trial and error. FertilityMap seeks to bring genetics into the equation, providing physicians with an additional tool to personalize and optimize infertility care.
FertilityMap is an IRB-approved research study aimed at uncovering the links between genomics and infertility.
While prior studies examined one or two genetic factors in relation to infertility, FertilityMap takes a large-scale, multivariate approach: analyzing hundreds of clinical variables and thousands of genetic variants in the context of each participant’s personal, pregnancy, and family medical history.
As we engineer this entirely new approach to fertility care, you and your staff are key to guiding study development and facilitating participant recruitment.